Acumen Pharmaceuticals (ABOS)
(Delayed Data from NSDQ)
$2.39 USD
-0.11 (-4.40%)
Updated Oct 3, 2024 04:00 PM ET
After-Market: $2.40 +0.01 (0.42%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-0.36 | 0.00% |
Earnings Summary
For their last quarter, Acumen Pharmaceuticals (ABOS) reported earnings of -$0.34 per share, missing the Zacks Consensus Estimate of -$0.28 per share. This reflects a negative earnings surprise of 21.43%. Look out for ABOS's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.36 per share, reflecting a year-over-year decrease of 50%.
Earnings History
Price & Consensus
Zacks News for ABOS
Acumen Pharmaceuticals (ABOS) Upgraded to Buy: What Does It Mean for the Stock?
ABOS: What are Zacks experts saying now?
Zacks Private Portfolio Services